SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Grant under Performance Share Plan

17 Mar 2022 17:14

RNS Number : 1963F
Forterra plc
17 March 2022
 

17 March 2022

Forterra plc

Grant under Performance Share Plan

Forterra plc (the "Company") announces that on 17 March 2022 awards over ordinary shares of £0.01 each in the capital of the Company were granted to certain Directors and persons discharging managerial responsibility ("PDMRs") under the Forterra plc Performance Share Plan ("PSP") as follows:

Name of Director / PDMR

Number of Shares over which the PSP Award is granted

Stephen Harrison

(Chief Executive Officer) 

298,002

Ben Guyatt

(Chief Financial Officer)

176,239

George Stewart

(Strategic Projects Director)

54,013

Adam Smith

(Commercial Director)

54,013

Shahbaz Idriss

(HR Director)

47,756

Darren Rix

(Managing Director - Bison Precast)

43,977

Matt Day

(IT Director)

43,964

Steve Jeynes

(Production Director)

43,831

Ashley Thompson

(Company Secretary)

11,681

Other management

 

252,718

Total awards granted

 

1,026,194

No consideration was paid for the grant of the awards which are structured as nominal cost options at an option exercise price of £0.01 per Ordinary Share. The number of Ordinary Shares granted under the award has been calculated using a share price of £2.31 being an average mid-market quotation as derived from the London Stock Exchange Daily Official List for the last 5 days of trading.

The vesting of an award is subject to the satisfaction of performance conditions which have been set by the Remuneration Committee of the Board of Directors of the Company. Half of the awards are subject to TSR and EPS performance measures respectively. The awards will normally vest on 17 March 2025, subject to the achievement of the performance conditions and the participant being a director or employee within the Company's group at that time.

Further information regarding the PSP is set out in the Annual Report and Accounts.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

 

 

Ashley Thompson (Company Secretary)

 

 

 

 

FTI Consulting (public relations adviser to Forterra):

+44 (0) 20 3727 1340

Richard Mountain

 

Nick Hasell

 

Forterra plc

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDXSGBDGDR
Date   Source Headline
6th Jul 20224:16 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSTransaction in Own Shares
5th Jul 202210:16 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20224:54 pmRNSDirector/PDMR Shareholding
4th Jul 20224:47 pmRNSEmployee Benefit Trust Share Purchase
1st Jul 20227:00 amRNSTransaction in Own Shares
30th Jun 20225:27 pmRNSTotal Voting Rights and Capital
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:30 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSShare buyback programme
27th Jun 20224:51 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20223:47 pmRNSEmployee Benefit Trust Share Purchase
7th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20229:52 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 202212:02 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 202210:26 amRNSProgressive publishes new research
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20224:30 pmRNSHolding(s) in Company
24th May 20224:15 pmRNSAnnual General Meeting 2022 Results
24th May 20228:00 amRNSTransaction in Own Shares
24th May 20227:00 amRNSBoard change
24th May 20227:00 amRNSAGM trading update
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.